NOAC Clinical Trials

2 actively recruiting trials

No change since May 2026

Also known as: Apixaban, Dabigatran, Edoxaban, Rivaroxaban

Pipeline

Phase 4: 1

Top Sponsors

University of Aarhus1
Medical University of Silesia1

Indications

Heart Disease2
Atrial Fibrillation2
Ischemic Stroke1
Stroke1

Other2 trials

Left Atrial Appendage Occlusion Versus Novel Oral Anticoagulation for Stroke Prevention in Atrial Fibrillation

N/A

Single-stage Pulmonary Vein Isolation Combined With Percutaneous Left Atrial Appendage Occluder Implantation in Patients With Recent Onset Ischemic Stroke and Atrial Fibrillation

Phase 4

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.